Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Mycobacterium tuberculosis gene expression at different stages of hypoxia-induced dormancy and upon resuscitation.

Iona E, Pardini M, Mustazzolu A, Piccaro G, Nisini R, Fattorini L, Giannoni F.

J Microbiol. 2016 Aug;54(8):565-72. doi: 10.1007/s12275-016-6150-4. Epub 2016 Aug 2.

PMID:
27480637
2.

Infection of human THP-1 cells with dormant Mycobacterium tuberculosis.

Iona E, Pardini M, Gagliardi MC, Colone M, Stringaro AR, Teloni R, Brunori L, Nisini R, Fattorini L, Giannoni F.

Microbes Infect. 2012 Sep;14(11):959-67. doi: 10.1016/j.micinf.2012.04.003. Epub 2012 Apr 14.

PMID:
22546526
3.

Bystander inhibition of dendritic cell differentiation by Mycobacterium tuberculosis-induced IL-10.

Remoli ME, Giacomini E, Petruccioli E, Gafa V, Severa M, Gagliardi MC, Iona E, Pine R, Nisini R, Coccia EM.

Immunol Cell Biol. 2011 Mar;89(3):437-46. doi: 10.1038/icb.2010.106. Epub 2010 Aug 31.

PMID:
20805841
4.

Activity of drug combinations against dormant Mycobacterium tuberculosis.

Filippini P, Iona E, Piccaro G, Peyron P, Neyrolles O, Fattorini L.

Antimicrob Agents Chemother. 2010 Jun;54(6):2712-5. doi: 10.1128/AAC.01736-09. Epub 2010 Mar 29.

5.

Characteristics of drug-resistant tuberculosis in Abkhazia (Georgia), a high-prevalence area in Eastern Europe.

Pardini M, Niemann S, Varaine F, Iona E, Meacci F, Orrù G, Yesilkaya H, Jarosz T, Andrew P, Barer M, Checchi F, Rinder H, Orefici G, Rüsch-Gerdes S, Fattorini L, Oggioni MR, Bonnet M.

Tuberculosis (Edinb). 2009 Jul;89(4):317-24. doi: 10.1016/j.tube.2009.04.002. Epub 2009 Jun 17.

PMID:
19539531
6.

The toll-like receptor 2/6 ligand MALP-2 reduces the viability of Mycobacterium tuberculosis in murine macrophages.

Palma C, Iona E, Ebensen T, Guzman CA, Cassone A.

Open Microbiol J. 2009 Apr 3;3:47-52. doi: 10.2174/1874285800903010047.

7.

The LTK63 adjuvant improves protection conferred by Ag85B DNA-protein prime-boosting vaccination against Mycobacterium tuberculosis infection by dampening IFN-gamma response.

Palma C, Iona E, Giannoni F, Pardini M, Brunori L, Fattorini L, Del Giudice G, Cassone A.

Vaccine. 2008 Aug 5;26(33):4237-43. doi: 10.1016/j.vaccine.2008.05.050. Epub 2008 Jun 12.

PMID:
18584925
8.

External quality control of Mycobacterium tuberculosis drug susceptibility testing: results of two rounds in endemic countries.

Fattorini L, Iona E, Cirillo D, Migliori GB, Orefici G, Aziz M, Wright A, Tafaj S, Baig B, Mulliqi G, Maungate S, Cuna Z, Al-Busaidy S, Al-Suwaidi Z, Ceyhan I.

Int J Tuberc Lung Dis. 2008 Feb;12(2):214-7.

PMID:
18230256
9.

Isolation of Nocardia asiatica from cutaneous ulcers of a human immunodeficiency virus-infected patient in Italy.

Iona E, Giannoni F, Brunori L, de Gennaro M, Mattei R, Fattorini L.

J Clin Microbiol. 2007 Jun;45(6):2088-9. Epub 2007 Apr 19.

10.

Validation of the agar proportion and 2 liquid systems for testing the susceptibility of Mycobacterium tuberculosis to moxifloxacin.

Piersimoni C, Lacchini C, Penati V, Iona E, Fattorini L, Nista D, Zallocco D, Gesu GP, Codecasa L.

Diagn Microbiol Infect Dis. 2007 Mar;57(3):283-7.

PMID:
17338942
11.

Pyrazinamide resistance in multidrug-resistant strains of Mycobacterium tuberculosis isolated in Abkhazia.

Pardini M, Varaine F, Hewison C, Iona E, Pataracchia M, Orefici G, Fattorini L.

J Chemother. 2007 Feb;19(1):106-7. No abstract available.

PMID:
17309862
12.

BCG-infected adherent mononuclear cells release cytokines that regulate group 1 CD1 molecule expression.

Prete SP, Giuliani A, D'Atri S, Graziani G, Balduzzi A, Oggioni MR, Iona E, Girolomoni G, Bonmassar L, Romani L, Franzese O.

Int Immunopharmacol. 2007 Mar;7(3):321-32. Epub 2006 Dec 8.

PMID:
17276890
13.

The Ag85B protein of Mycobacterium tuberculosis may turn a protective immune response induced by Ag85B-DNA vaccine into a potent but non-protective Th1 immune response in mice.

Palma C, Iona E, Giannoni F, Pardini M, Brunori L, Orefici G, Fattorini L, Cassone A.

Cell Microbiol. 2007 Jun;9(6):1455-65. Epub 2007 Jan 22.

PMID:
17250590
14.

Metronidazole plus rifampin sterilizes long-term dormant Mycobacterium tuberculosis.

Iona E, Giannoni F, Pardini M, Brunori L, Orefici G, Fattorini L.

Antimicrob Agents Chemother. 2007 Apr;51(4):1537-40. Epub 2007 Jan 22.

15.

Immune response and protection by DNA vaccines expressing antigen 85B of Mycobacterium tuberculosis.

Pardini M, Giannoni F, Palma C, Iona E, Cafaro A, Brunori L, Rinaldi M, Fazio VM, Laguardia ME, Carbonella DC, Magnani M, Ensoli B, Fattorini L, Cassone A.

FEMS Microbiol Lett. 2006 Sep;262(2):210-5.

16.

Infection of human dendritic cells with a Mycobacterium tuberculosis sigE mutant stimulates production of high levels of interleukin-10 but low levels of CXCL10: impact on the T-cell response.

Giacomini E, Sotolongo A, Iona E, Severa M, Remoli ME, Gafa V, Lande R, Fattorini L, Smith I, Manganelli R, Coccia EM.

Infect Immun. 2006 Jun;74(6):3296-304.

17.

Does one size fit all? Drug resistance and standard treatments: results of six tuberculosis programmes in former Soviet countries.

Bonnet M, Sizaire V, Kebede Y, Janin A, Doshetov D, Mirzoian B, Arzumanian A, Muminov T, Iona E, Rigouts L, Rüsch-Gerdes S, Varaine F.

Int J Tuberc Lung Dis. 2005 Oct;9(10):1147-54.

PMID:
16229227
18.

Drug resistance evolution of a Mycobacterium tuberculosis strain from a noncompliant patient.

Meacci F, Orrù G, Iona E, Giannoni F, Piersimoni C, Pozzi G, Fattorini L, Oggioni MR.

J Clin Microbiol. 2005 Jul;43(7):3114-20.

19.

Evaluation of a new line probe assay for rapid identification of gyrA mutations in Mycobacterium tuberculosis.

Giannoni F, Iona E, Sementilli F, Brunori L, Pardini M, Migliori GB, Orefici G, Fattorini L.

Antimicrob Agents Chemother. 2005 Jul;49(7):2928-33.

20.

Mycobacterium tuberculosis drug resistance, Abkhazia.

Pardini M, Iona E, Varaine F, Karakozian H, Arzumanian H, Brunori L, Orefici G, Fattorini L; LONG-DRUG Study Group.

Emerg Infect Dis. 2005 Mar;11(3):501-3. No abstract available.

21.

Cetyl-pyridinium chloride is useful for isolation of Mycobacterium tuberculosis from sputa subjected to long-term storage.

Pardini M, Varaine F, Iona E, Arzumanian E, Checchi F, Oggioni MR, Orefici G, Fattorini L.

J Clin Microbiol. 2005 Jan;43(1):442-4.

22.
23.

Mycobacterium tuberculosis diverts alpha interferon-induced monocyte differentiation from dendritic cells into immunoprivileged macrophage-like host cells.

Mariotti S, Teloni R, Iona E, Fattorini L, Romagnoli G, Gagliardi MC, Orefici G, Nisini R.

Infect Immun. 2004 Aug;72(8):4385-92.

24.

The extra cytoplasmic function sigma factor sigma(E) is essential for Mycobacterium tuberculosis virulence in mice.

Manganelli R, Fattorini L, Tan D, Iona E, Orefici G, Altavilla G, Cusatelli P, Smith I.

Infect Immun. 2004 May;72(5):3038-41.

25.

An anti-inflammatory role for V alpha 14 NK T cells in Mycobacterium bovis bacillus Calmette-Guérin-infected mice.

Dieli F, Taniguchi M, Kronenberg M, Sidobre S, Ivanyi J, Fattorini L, Iona E, Orefici G, De Leo G, Russo D, Caccamo N, Sireci G, Di Sano C, Salerno A.

J Immunol. 2003 Aug 15;171(4):1961-8.

26.

IFN-alpha beta released by Mycobacterium tuberculosis-infected human dendritic cells induces the expression of CXCL10: selective recruitment of NK and activated T cells.

Lande R, Giacomini E, Grassi T, Remoli ME, Iona E, Miettinen M, Julkunen I, Coccia EM.

J Immunol. 2003 Feb 1;170(3):1174-82.

27.

Activities of moxifloxacin alone and in combination with other antimicrobial agents against multidrug-resistant Mycobacterium tuberculosis infection in BALB/c mice.

Fattorini L, Tan D, Iona E, Mattei M, Giannoni F, Brunori L, Recchia S, Orefici G.

Antimicrob Agents Chemother. 2003 Jan;47(1):360-2.

28.

Involvement of the fadD33 gene in the growth of Mycobacterium tuberculosis in the liver of BALB/c mice.

Rindi L, Fattorini L, Bonanni D, Iona E, Freer G, Tan D, Dehò G, Orefici G, Garzelli C.

Microbiology. 2002 Dec;148(Pt 12):3873-80.

PMID:
12480891
29.

Recombinant GroES in combination with CpG oligodeoxynucleotides protects mice against Mycobacterium avium infection.

Fattorini L, Creti R, Nisini R, Pietrobono R, Fan Y, Stringaro A, Arancia G, Serlupi-Crescenzi O, Iona E, Orefici G.

J Med Microbiol. 2002 Dec;51(12):1071-9.

PMID:
12466405
30.

Mycobacterium tuberculosis subverts the differentiation of human monocytes into dendritic cells.

Mariotti S, Teloni R, Iona E, Fattorini L, Giannoni F, Romagnoli G, Orefici G, Nisini R.

Eur J Immunol. 2002 Nov;32(11):3050-8.

31.

Exposure of BALB/c mice to low doses of Mycobacterium avium increases resistance to a subsequent high-dose infection.

Fattorini L, Nisini R, Fan Y, Li YJ, Tan D, Mariotti S, Teloni R, Iona E, Orefici G.

Microbiology. 2002 Oct;148(Pt 10):3173-81.

PMID:
12368451
32.

Prevalence of resistance to anti-tuberculosis drugs: results of the 1998/99 national survey in Italy.

Migliori GB, Fattorini L, Vaccarino P, Besozzi G, Saltini C, Orefici G, Iona E, Matteelli A, Fiorentini F, Codecasa LR, Casali L, Cassone A; SMIRA (Italian Multicentre Study on Resistance to Anti-tuberculosis drugs) Study Group.

Int J Tuberc Lung Dis. 2002 Jan;6(1):32-8.

PMID:
11931399
33.

Influence of Mycobacterium bovis bacillus Calmette Guérin on in vitro induction of CD1 molecules in human adherent mononuclear cells.

Giuliani A, Prete SP, Graziani G, Aquino A, Balduzzi A, Sugita M, Brenner MB, Iona E, Fattorini L, Orefici G, Porcelli SA, Bonmassar E.

Infect Immun. 2001 Dec;69(12):7461-70.

34.

Infection of human macrophages and dendritic cells with Mycobacterium tuberculosis induces a differential cytokine gene expression that modulates T cell response.

Giacomini E, Iona E, Ferroni L, Miettinen M, Fattorini L, Orefici G, Julkunen I, Coccia EM.

J Immunol. 2001 Jun 15;166(12):7033-41.

35.

Bacillus Calmette-Guerin down-regulates CD1b induction by granulocyte-macrophage colony stimulating factor in human peripheral blood monocytes.

Prete SP, Giuliani A, Iona E, Fattorini L, Orefici G, Franzese O, Bonmassar E, Graziani G.

J Chemother. 2001 Feb;13(1):52-8.

PMID:
11233801
36.

Virulence and drug susceptibility of Mycobacterium celatum.

Fattorini L, Baldassarri L, Li YJ, Ammendolia MG, Fan Y, Recchia S, Iona E, Orefici G.

Microbiology. 2000 Nov;146 ( Pt 11):2733-42.

PMID:
11065352
37.

Activity of 16 antimicrobial agents against drug-resistant strains of Mycobacterium tuberculosis.

Fattorini L, Iona E, Ricci ML, Thoresen OF, Orrù G, Oggioni MR, Tortoli E, Piersimoni C, Chiaradonna P, Tronci M, Pozzi G, Orefici G.

Microb Drug Resist. 1999 Winter;5(4):265-70.

PMID:
10647084
38.

Activities of eighteen antimicrobial regimens against Mycobacterium avium infection in beige mice.

Fattorini L, Xiao Y, Mattei M, Li Y, Iona E, Thoresen OF, Orefici G.

Microb Drug Resist. 1999 Fall;5(3):227-33.

PMID:
10566874
39.

Mycobacterium avium infection in BALB/c and SCID mice.

Fattorini L, Mattei M, Placido R, Li B, Iona E, Agrimi U, Colizzi V, Orefici G.

J Med Microbiol. 1999 Jun;48(6):577-83.

PMID:
10359307
40.

rpoB mutations in multidrug-resistant strains of Mycobacterium tuberculosis isolated in Italy.

Pozzi G, Meloni M, Iona E, Orrù G, Thoresen OF, Ricci ML, Oggioni MR, Fattorini L, Orefici G.

J Clin Microbiol. 1999 Apr;37(4):1197-9.

41.

Antimicrobial activity of fluoroquinolones and other antibiotics on 1,116 clinical gram-positive and gram-negative isolates.

Mascellino MT, Farinelli S, Iegri F, Iona E, De Simone C.

Drugs Exp Clin Res. 1998;24(3):139-51.

PMID:
9825230
42.

Typing of human Mycobacterium avium isolates in Italy by IS1245-based restriction fragment length polymorphism analysis.

Lari N, Cavallini M, Rindi L, Iona E, Fattorini L, Garzelli C.

J Clin Microbiol. 1998 Dec;36(12):3694-7.

43.

Activities of isoniazid alone and in combination with other drugs against Mycobacterium avium infection in beige mice.

Fattorini L, Xiao Y, Mattei M, Li Y, Iona E, Ricci ML, Thoresen OF, Creti R, Orefici G.

Antimicrob Agents Chemother. 1998 Mar;42(3):712-4.

44.

The influence of the SOS response on the activity of 4-quinolones and zidovudine against some strains of Enterobacteria.

Mascellino MT, Farinelli S, Iegri F, Iona E.

New Microbiol. 1998 Jan;21(1):31-40.

PMID:
9497927
45.

["Killing" of pseudomonas aeruginosa isolated from patients with critical post-operative complications. Effect of various antibiotics].

Delogu G, Iona E, Amati F, Marandola M, Costantini D, Baumgartner IM, Mascellino MT.

Ann Ital Chir. 1997 Mar-Apr;68(2):219-24. Italian.

PMID:
9290013
46.

Type frequency and antimicrobial susceptibility of Mycobacterium avium-intracellulare complex strains isolated in Italy from AIDS and non-AIDS patients.

Fattorini L, Vincent V, Li B, Xiao Y, Varnerot A, Tortoli E, Piersimoni C, Mandler F, Mascellino MT, Iona E, Orefici G.

J Chemother. 1996 Feb;8(1):37-42.

PMID:
8835106
47.

Rapid detection of mycobacteria by combining a radiometric detection system with DNA probes.

Mascellino MT, Rossi F, Iegri F, Iona E.

New Microbiol. 1994 Jul;17(3):249-53.

PMID:
7968660
48.

Activity of antimicrobial drugs evaluated by agar dilution and radiometric methods against strains of Nocardia asteroides isolated in Italy from immunocompromised patients.

Scopetti F, Iona E, Fattorini L, Goglio A, Franceschini N, Amicosante G, Orefici G.

J Chemother. 1994 Feb;6(1):29-34.

PMID:
8071674
49.

Infections due to Rhodococcus equi in three HIV-infected patients: microbiological findings and antibiotic susceptibility.

Mascellino MT, Iona E, Ponzo R, Mastroianni CM, Delia S.

Int J Clin Pharmacol Res. 1994;14(5-6):157-63.

PMID:
7672872
50.

In vitro activity of zidovudine alone and in combination with ciprofloxacin against Salmonella and Escherichia coli.

Mascellino MT, Iona E, Iegri F, De Gregoris P, Farinelli S.

FEMS Immunol Med Microbiol. 1993 Jun;7(1):23-8.

PMID:
8364519

Supplemental Content

Support Center